A Study of JNJ-67484703 in Participants With Active Rheumatoid Arthritis

NCT04985812 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: JNJ-67484703
DRUG: Placebo

Sponsor

Janssen Research & Development, LLC